Vernalis PLC (Formerly Known As British Biotech PLC)
Watlington Road
Oxford
OX4 5LY
United Kingdom
Tel: 01865-748747
Fax: 01865-781047
Website: http://www.britishbiotech.com/
Email: gm@greenwich-medical.co.uk
About Vernalis PLC (Formerly Known As British Biotech PLC)
135 articles about Vernalis PLC (Formerly Known As British Biotech PLC)
-
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
9/25/2023
Pierre Fabre Laboratories and Vernalis Ltd, a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets.
-
HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery
10/12/2020
HITGEN announces it has entered into a definitive agreement with Ligand Pharmaceuticals Inc. to acquire Vernalis Limited, Cambridge, UK-based world leaders in fragment and structure-based drug discovery research.
-
Ligand Announces the Close of its Acquisition of Vernalis
10/10/2018
Ligand’s portfolio now includes more than 178 shots on goal
-
Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash
8/9/2018
Ligand to gain broad portfolio of partnered and unpartnered programs, a self-funding R&D group and approximately $32 million of net cash
-
Vernalis PLC: AGM Statement With Strong Unaudited Cash Position
12/15/2017
Vernalis plc provides an update ahead of its Annual General Meeting being held today at 10.30 am at the offices of Covington & Burling, 265 Strand, London WC2R 1BH.
-
Vernalis + Daiichi Sankyo Enter Collaboration
12/13/2017
The financial terms of this collaboration are not disclosed.
-
Vernalis: Results Announcement For The Year Ended 30 June 2017
9/12/2017
-
Vernalis Hit by U.S. Setback for Cough and Cold Drug CCP-08
8/7/2017
-
Vernalis PLC: Year-End Trading Update And Notice Of Full Year Results
7/19/2017
-
Servier And Vernalis PLC Announce Achievement Of 3 Milestones In Their Oncology Drug Discovery Collaboration
4/27/2017
-
Vernalis PLC: FDA Issues A Complete Response Letter On CCP-07 NDA
4/24/2017
-
Vernalis PLC Tanks After the FDA Spurns Cough-Cold Drug Filing
4/21/2017
-
Vernalis PLC: Unaudited Interim Results For The Six Months Ended 31 December 2016
2/21/2017
-
Vernalis PLC Achieves A $3 Million Milestone Payment From Corvus Pharma
2/14/2017
-
Vernalis PLC: Notice Of Results For Six Months Ended 31/12/2016
1/30/2017
-
Vernalis PLC: AGM Statement
11/30/2016
-
Vernalis PLC Begins Promotion Of MOXATAG (Amoxicillin Extended-Release) Tablets To Primary Care Physicians In The US
10/11/2016
-
Vernalis PLC Announces Results Announcement For The 12 Months Ended 30 June 2016
9/29/2016
-
Vernalis PLC Release: FDA Accepts CCP-07 NDA For Full Review
9/6/2016
-
Vernalis PLC Achieves A Milestone In Its Oncology Collaboration With Servier
7/19/2016